|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6521211B1
(en)
*
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US6821506B2
(en)
|
1995-06-08 |
2004-11-23 |
Barnes-Jewish Hospital |
Site specific binding system, imaging compositions and methods
|
|
US6548046B1
(en)
|
1995-06-08 |
2003-04-15 |
Barnes-Jewish Hospital |
Site specific binding system, imaging compositions and methods
|
|
US5780010A
(en)
*
|
1995-06-08 |
1998-07-14 |
Barnes-Jewish Hospital |
Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
|
|
ATE345682T1
(de)
|
1996-05-01 |
2006-12-15 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
DE69735354T2
(de)
|
1996-10-28 |
2006-11-30 |
Amersham Health As |
Verbesserungen an oder in verbindung mit diagnostischen/therapeutischen verbindungen
|
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
|
US6493570B1
(en)
*
|
1998-11-02 |
2002-12-10 |
Photogen, Inc. |
Method for improved imaging and photodynamic therapy
|
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US7452551B1
(en)
*
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
*
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
US6245318B1
(en)
|
1997-05-27 |
2001-06-12 |
Mallinckrodt Inc. |
Selectively binding ultrasound contrast agents
|
|
AU9400798A
(en)
*
|
1997-09-18 |
1999-04-05 |
University Of Pittsburgh |
Icam-1 selective echogenic microbubbles
|
|
DE69814428T2
(de)
†
|
1997-09-29 |
2004-05-13 |
Nektar Therapeutics, San Carlos |
In verneblern verwendbare, stabilisierte zubereitungen
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
EP1024837A1
(en)
*
|
1997-10-21 |
2000-08-09 |
Nycomed Imaging As |
Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
CA2727746A1
(en)
*
|
1998-12-18 |
2000-06-22 |
Bristol-Myers Squibb Pharma Company |
Quinolone vitronectin receptor antagonist pharmaceuticals
|
|
AU783647B2
(en)
*
|
1999-04-20 |
2005-11-17 |
University Of British Columbia, The |
Cationic peg-lipids and methods of use
|
|
US6254852B1
(en)
|
1999-07-16 |
2001-07-03 |
Dupont Pharmaceuticals Company |
Porous inorganic targeted ultrasound contrast agents
|
|
AU6522400A
(en)
*
|
1999-08-10 |
2001-03-05 |
Imarx Therapeutics, Inc. |
Targeted thrombolytic agents
|
|
US7220401B2
(en)
|
1999-09-24 |
2007-05-22 |
Barnes-Jewish Hospital |
Blood clot-targeted nanoparticles
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
AU2001266696A1
(en)
|
2000-06-02 |
2001-12-11 |
Bracco Research Usa |
Compounds for targeting endothelial cells
|
|
US8263739B2
(en)
|
2000-06-02 |
2012-09-11 |
Bracco Suisse Sa |
Compounds for targeting endothelial cells, compositions containing the same and methods for their use
|
|
AU2002214583A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Purdue Research Foundation |
Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof
|
|
US7829074B2
(en)
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
|
US7087212B2
(en)
|
2001-08-17 |
2006-08-08 |
Mallinckrodt, Inc |
Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
|
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
TR200401834T2
(tr)
*
|
2002-01-24 |
2005-10-21 |
Barnes-Jewish Hospital |
İntegrin hedefli görüntüleme etken maddeleri.
|
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US7666979B2
(en)
|
2002-03-01 |
2010-02-23 |
Bracco International B.V. |
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
|
|
US7211240B2
(en)
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
|
EP1587944A4
(en)
|
2002-03-01 |
2007-03-21 |
Dyax Corp |
KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
|
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
JP2005529137A
(ja)
*
|
2002-04-29 |
2005-09-29 |
ビオテシス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
生体系における輸送系
|
|
KR101025143B1
(ko)
|
2002-12-31 |
2011-04-01 |
넥타르 테라퓨틱스 |
가수분해상으로 안정한 말레이미드－종결 중합체
|
|
US7432331B2
(en)
|
2002-12-31 |
2008-10-07 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
US20070128117A1
(en)
*
|
2003-02-04 |
2007-06-07 |
Bracco International B.V. |
Ultrasound contrast agents and process for the preparation thereof
|
|
ES2396368T3
(es)
|
2003-03-03 |
2013-02-21 |
Dyax Corporation |
Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
|
|
EP1638504A4
(en)
*
|
2003-06-13 |
2011-07-20 |
Cerevast Therapeutics Inc |
NONINVASIVE INTRAVASCULAR THROMBOLYSIS WITH MODIFIED ULTRASOUND TECHNIQUES
|
|
US7358226B2
(en)
|
2003-08-27 |
2008-04-15 |
The Regents Of The University Of California |
Ultrasonic concentration of drug delivery capsules
|
|
WO2005027808A1
(en)
|
2003-09-12 |
2005-03-31 |
Z-Medica Corporation |
Calcium zeolite hemostatic agent
|
|
CN1321697C
(zh)
*
|
2003-12-23 |
2007-06-20 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种以磷脂类成分为成膜材料的超声造影剂组合物及其制备方法
|
|
US8012457B2
(en)
*
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
|
US11167058B2
(en)
|
2005-02-15 |
2021-11-09 |
Virginia Commonwealth University |
Hemostasis of wound having high pressure blood flow
|
|
US9326995B2
(en)
|
2005-04-04 |
2016-05-03 |
The Regents Of The University Of California |
Oxides for wound healing and body repair
|
|
CN100402092C
(zh)
*
|
2005-06-07 |
2008-07-16 |
西安交通大学 |
血栓诊断和/或治疗用含气干粉活性剂及其制备工艺
|
|
JP2007001923A
(ja)
*
|
2005-06-23 |
2007-01-11 |
Shinshu Univ |
Ｎ−アセチルグルコサミン糖鎖認識タンパク質
|
|
MX2008007321A
(es)
*
|
2005-12-09 |
2008-09-30 |
Bracco Int Bv |
Conjugados fosfolipido de vector dirigido.
|
|
US8938898B2
(en)
|
2006-04-27 |
2015-01-27 |
Z-Medica, Llc |
Devices for the identification of medical products
|
|
US7604819B2
(en)
|
2006-05-26 |
2009-10-20 |
Z-Medica Corporation |
Clay-based hemostatic agents and devices for the delivery thereof
|
|
EP2117603A2
(en)
|
2006-12-19 |
2009-11-18 |
Bracco International B.V. |
Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
|
|
WO2008123478A1
(en)
*
|
2007-03-29 |
2008-10-16 |
Canon Kabushiki Kaisha |
Active energy ray curable liquid composition and liquid cartridge
|
|
DE102007041832A1
(de)
*
|
2007-09-03 |
2009-03-05 |
Siemens Ag |
Arzneimittel und Verfahren zur Behandlung von Prostatakrebs
|
|
WO2010005740A2
(en)
*
|
2008-06-16 |
2010-01-14 |
Bind Biosciences, Inc. |
Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
|
|
CN101721719B
(zh)
*
|
2008-10-28 |
2011-09-28 |
温州医学院 |
超声造影剂及其制备方法
|
|
CN101549161B
(zh)
*
|
2009-05-13 |
2010-12-01 |
中南大学 |
一种肝、脾脏特异性阳性核磁共振对比剂及其制备方法
|
|
WO2010139003A1
(en)
*
|
2009-06-01 |
2010-12-09 |
Commonwealth Scientific And Industrial Research Organisation |
Chelating amphiphiles
|
|
US8858969B2
(en)
|
2010-09-22 |
2014-10-14 |
Z-Medica, Llc |
Hemostatic compositions, devices, and methods
|
|
EP3412320A1
(en)
|
2012-06-22 |
2018-12-12 |
Z-Medica, LLC |
Hemostatic devices
|
|
US10035009B2
(en)
|
2013-04-15 |
2018-07-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for treating pancreatic cancer
|
|
CN117018234A
(zh)
*
|
2013-08-16 |
2023-11-10 |
加利福尼亚大学董事会 |
硅酮基肠道ct对比材料
|
|
KR102031571B1
(ko)
*
|
2014-03-07 |
2019-10-14 |
주식회사 퍼시픽시스템 |
약물 전달을 위해 기포를 포함하는 미셀 및 이를 제조하는 방법
|
|
EP3167277A4
(en)
*
|
2014-07-08 |
2018-03-07 |
Agency For Science, Technology And Research |
Ultrashort peptides as exogenous second harmonic probes for bioimaging applications
|
|
CA2965091A1
(en)
*
|
2014-10-20 |
2016-05-06 |
Dorian Averbuch |
Surgical devices and methods of use thereof
|
|
KR102618877B1
(ko)
|
2014-12-31 |
2023-12-28 |
랜티우스 메디컬 이메징, 인크. |
지질-캡슐화된 기체 마이크로스피어 조성물 및 관련 방법
|
|
EP3452108A4
(en)
|
2016-05-04 |
2019-12-25 |
Lantheus Medical Imaging, Inc. |
METHOD AND DEVICES FOR THE PRODUCTION OF ULTRASONIC CONTRASTING AGENTS
|
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
|
JP7500536B2
(ja)
*
|
2018-03-23 |
2024-06-17 |
アデノサイト リミテッド |
強化された細胞病理学的細胞採取のための細胞および／または組織片の剥離を誘導する方法
|
|
CN110591054B
(zh)
*
|
2019-09-17 |
2021-05-18 |
江苏泰特尔新材料科技股份有限公司 |
一种总氯含量低、无重金属残留的环氧化物及其合成工艺
|
|
CN112266930B
(zh)
*
|
2020-10-14 |
2023-03-14 |
中国科学院苏州生物医学工程技术研究所 |
超声穿孔转染细胞的方法
|
|
CN113694215B
(zh)
*
|
2021-09-09 |
2023-12-29 |
南京超维景生物科技有限公司 |
磁性纳米滴液的组合物，磁性造影剂及其制备方法
|